DE602005023592D1 - Endothelvorläuferzellen und verfahren zur verwendung davon - Google Patents
Endothelvorläuferzellen und verfahren zur verwendung davonInfo
- Publication number
- DE602005023592D1 DE602005023592D1 DE602005023592T DE602005023592T DE602005023592D1 DE 602005023592 D1 DE602005023592 D1 DE 602005023592D1 DE 602005023592 T DE602005023592 T DE 602005023592T DE 602005023592 T DE602005023592 T DE 602005023592T DE 602005023592 D1 DE602005023592 D1 DE 602005023592D1
- Authority
- DE
- Germany
- Prior art keywords
- precursor cells
- endothelial precursor
- cells
- immunoreactive
- endothelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000003511 endothelial effect Effects 0.000 title abstract 2
- 239000002243 precursor Substances 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 2
- BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 abstract 1
- 101100481408 Danio rerio tie2 gene Proteins 0.000 abstract 1
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 abstract 1
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 abstract 1
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 abstract 1
- 101100481410 Mus musculus Tek gene Proteins 0.000 abstract 1
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 abstract 1
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 abstract 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 210000005166 vasculature Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464402—Receptors, cell surface antigens or cell surface determinants
- A61K39/464403—Receptors for growth factors
- A61K39/464409—Vascular endothelial growth factor receptors [VEGFR]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
- C12N5/0692—Stem cells; Progenitor cells; Precursor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Developmental Biology & Embryology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55159404P | 2004-03-09 | 2004-03-09 | |
PCT/IB2005/001072 WO2005085424A2 (en) | 2004-03-09 | 2005-03-09 | Endothelial progenitor cells and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005023592D1 true DE602005023592D1 (de) | 2010-10-28 |
Family
ID=34919593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005023592T Active DE602005023592D1 (de) | 2004-03-09 | 2005-03-09 | Endothelvorläuferzellen und verfahren zur verwendung davon |
Country Status (8)
Country | Link |
---|---|
US (2) | US20050201990A1 (de) |
EP (1) | EP1737949B1 (de) |
JP (2) | JP2007528222A (de) |
AT (1) | ATE481477T1 (de) |
AU (1) | AU2005219660B2 (de) |
CA (1) | CA2559110A1 (de) |
DE (1) | DE602005023592D1 (de) |
WO (1) | WO2005085424A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1737949B1 (de) * | 2004-03-09 | 2010-09-15 | Absorber AB | Endothelvorläuferzellen und verfahren zur verwendung davon |
JP2010520181A (ja) * | 2007-03-02 | 2010-06-10 | ナショナル・ユニバーシティ・オブ・アイルランド・ゴルウェイ | 心血管疾患の予測および治療のためのオステオポンチン |
KR20180034707A (ko) | 2008-11-04 | 2018-04-04 | 인리젠 | 세포-지지체 구조물 |
EP2198873A1 (de) * | 2008-12-18 | 2010-06-23 | Aposcience AG | Pharmazeutisches Präparat, enthaltend den Überstand einer Blutmononuklearzellkultur |
EP2201954A1 (de) * | 2008-12-18 | 2010-06-30 | Aposcience AG | Pharmazeutisches Präparat |
US20120233218A1 (en) * | 2011-03-09 | 2012-09-13 | Christopher Liam Ivey | System and Method for Delivering Brand Reinforcement as a Component of a Human Interactive Proof |
US20120295347A1 (en) * | 2011-05-20 | 2012-11-22 | Steven Kessler | Methods and Compositions for Producing Endothelial Progenitor Cells from Pluripotent Stem Cells |
CN105473134B (zh) | 2013-06-05 | 2021-04-27 | 再生疗法有限公司 | 用于哺乳动物物种中诱导性组织再生的组合物和方法 |
US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
CN106699885B (zh) * | 2015-11-18 | 2020-03-24 | 北京步长新药研发有限公司 | 一种人源抗vegfr2抗体及其应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4352883A (en) * | 1979-03-28 | 1982-10-05 | Damon Corporation | Encapsulation of biological material |
US4353888A (en) * | 1980-12-23 | 1982-10-12 | Sefton Michael V | Encapsulation of live animal cells |
NO155316C (no) * | 1982-04-23 | 1987-03-11 | Sintef | Fremgangsmaate for fremstilling av magnetiske polymerpartikler. |
US5130144B1 (en) * | 1984-02-06 | 1995-08-15 | Univ Johns Hopkins | Human stem cells and monoclonal antibodies |
US4965204A (en) * | 1984-02-06 | 1990-10-23 | The Johns Hopkins University | Human stem cells and monoclonal antibodies |
US4714680B1 (en) * | 1984-02-06 | 1995-06-27 | Univ Johns Hopkins | Human stem cells |
US5026365A (en) * | 1987-04-29 | 1991-06-25 | The University Of Massachusetts | Method and apparatus for therapeutically treating immunological disorders and disease states |
ES2035317T5 (es) * | 1987-11-09 | 1998-03-16 | Becton Dickinson Co | Metodo para analizar celulas hematopoyeticas en una muestra. |
US5158881A (en) * | 1987-11-17 | 1992-10-27 | Brown University Research Foundation | Method and system for encapsulating cells in a tubular extrudate in separate cell compartments |
US5283187A (en) * | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
US5071741A (en) * | 1988-04-18 | 1991-12-10 | Cryolife, Inc. | Cryoprotective agent and its use in cryopreservation of cellular matter |
DE3829766A1 (de) * | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Verfahren zur herstellung von membranen |
DE3829752A1 (de) * | 1988-09-01 | 1990-03-22 | Akzo Gmbh | Integrale asymmetrische polyaethersulfonmembran, verfahren zur herstellung und verwendung zur ultrafiltration und mikrofiltration |
US5084350A (en) * | 1990-02-16 | 1992-01-28 | The Royal Institution For The Advance Of Learning (Mcgill University) | Method for encapsulating biologically active material including cells |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
DE69221484T2 (de) * | 1991-04-25 | 1998-02-19 | Univ Brown Res Found | Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte |
US5955291A (en) * | 1992-01-09 | 1999-09-21 | Alitalo; Kari | Antibodies recognizing tie receptor tyrosine kinase and uses thereof |
WO1993017671A1 (en) * | 1992-03-06 | 1993-09-16 | Statens Seruminstitut | Treatment and prophylaxis of diseases caused by parasites, or bacteria |
US5840502A (en) * | 1994-08-31 | 1998-11-24 | Activated Cell Therapy, Inc. | Methods for enriching specific cell-types by density gradient centrifugation |
US6060643A (en) * | 1995-08-04 | 2000-05-09 | Emory University | Mouse model with human immune system |
US5942385A (en) * | 1996-03-21 | 1999-08-24 | Sugen, Inc. | Method for molecular diagnosis of tumor angiogenesis and metastasis |
US5843633A (en) * | 1996-04-26 | 1998-12-01 | Amcell Corporation | Characterization of a human hematopoietic progenitor cell antigen |
US20030125615A1 (en) * | 1998-02-05 | 2003-07-03 | Yitzhack Schwartz | Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
US20030100107A1 (en) * | 1998-05-29 | 2003-05-29 | Thomas Jefferson University | Compositions and methods for generating differentiated human cells |
US20020150876A1 (en) * | 2000-03-30 | 2002-10-17 | Pippig Susanne Dagmar | Selectable marker genes |
GB0015923D0 (en) * | 2000-06-30 | 2000-08-23 | Astrazeneca Ab | Methods |
EP1737949B1 (de) * | 2004-03-09 | 2010-09-15 | Absorber AB | Endothelvorläuferzellen und verfahren zur verwendung davon |
-
2005
- 2005-03-09 EP EP05718509A patent/EP1737949B1/de not_active Not-in-force
- 2005-03-09 JP JP2007502440A patent/JP2007528222A/ja active Pending
- 2005-03-09 CA CA002559110A patent/CA2559110A1/en not_active Abandoned
- 2005-03-09 WO PCT/IB2005/001072 patent/WO2005085424A2/en active Application Filing
- 2005-03-09 AT AT05718509T patent/ATE481477T1/de not_active IP Right Cessation
- 2005-03-09 AU AU2005219660A patent/AU2005219660B2/en not_active Ceased
- 2005-03-09 US US11/076,668 patent/US20050201990A1/en not_active Abandoned
- 2005-03-09 DE DE602005023592T patent/DE602005023592D1/de active Active
-
2008
- 2008-12-08 US US12/329,829 patent/US20090148423A1/en not_active Abandoned
-
2012
- 2012-07-25 JP JP2012164885A patent/JP2012210227A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2005219660A1 (en) | 2005-09-15 |
JP2012210227A (ja) | 2012-11-01 |
JP2007528222A (ja) | 2007-10-11 |
WO2005085424A3 (en) | 2006-05-18 |
US20050201990A1 (en) | 2005-09-15 |
CA2559110A1 (en) | 2005-09-15 |
AU2005219660B2 (en) | 2009-07-16 |
EP1737949A2 (de) | 2007-01-03 |
EP1737949B1 (de) | 2010-09-15 |
WO2005085424A2 (en) | 2005-09-15 |
US20090148423A1 (en) | 2009-06-11 |
ATE481477T1 (de) | 2010-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005023592D1 (de) | Endothelvorläuferzellen und verfahren zur verwendung davon | |
ATE548447T1 (de) | Menschlicher hepatische vorläuferzellen und verfahren zur verwendung davon | |
ATE486126T1 (de) | Lebervorläuferzellen | |
WO2007030469A3 (en) | Transplantable cell growth niche and related compositions and methods | |
NZ569543A (en) | Means and methods for influencing the stability of antibody producing cells | |
EP1783209A4 (de) | Selektives kultivierungsverfahren und trennverfahren für kleine hepatozyten mit verwendung von hyaluronsäure | |
MX2012007414A (es) | Diferenciacion de celulas madres embrionarias humanas. | |
DE602005018981D1 (de) | Verfahren zur Herstellung von L-Cystein, und L-Cystein-produzierender Mikroorganismus | |
WO2007115336A3 (en) | A shape-based approach for scaffoldless tissue engineering | |
ATE480615T1 (de) | Verfahren zur proliferation von stammzellen | |
PT2447357E (pt) | Processos para produzir microfolículos capilares e papilas de novo e respetiva utilização em testes in vitro e em implantes in vivo¿ | |
MY146352A (en) | Adipose derived adult stem cells in hepatic regeneration | |
HK1093755A1 (en) | Method for differentiating mesenchymal stem cell into neural cell | |
NZ591812A (en) | Cell culture method to form aggregates | |
GB2453074A (en) | Differentiation of primate pluripotent cells to hepatocyte-lineage cells | |
DE602005018353D1 (de) | Fermentierter Tee und Verfahren zur Herstellung von fermentiertem Tee | |
EP3031326A3 (de) | Knochenmarkabgeleitete mesenchymale stammzellen als quelle für neurale vorläufer | |
ATE544849T1 (de) | Aktivierte dendritische zellen, therapieverfahren unter verwendung der dendritischen zellen sowie verfahren zur kultivierung von gamma-delta-t- zellen | |
JP2007528222A5 (de) | ||
WO2006032054A3 (en) | Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair | |
DE502005006003D1 (de) | Verfahren zur herstellung einer epithelzellen enthaltenden zellzusammensetzung | |
ATE458808T1 (de) | Verfahren zur herstellung einer voll entwickelten natürlichen killerzelle | |
WO2011097242A3 (en) | Methods of isolating and culturing mesenchymal stem cells | |
WO2008058942A3 (en) | Method of cell culture and method of treatment comprising a vepo protein variant | |
EP1878789A4 (de) | Aus fett stammende vorläuferzelle und verwendung davon |